Correlation Between Scpharmaceuticals and Blueprint Medicines
Can any of the company-specific risk be diversified away by investing in both Scpharmaceuticals and Blueprint Medicines at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scpharmaceuticals and Blueprint Medicines into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Scpharmaceuticals and Blueprint Medicines Corp, you can compare the effects of market volatilities on Scpharmaceuticals and Blueprint Medicines and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scpharmaceuticals with a short position of Blueprint Medicines. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scpharmaceuticals and Blueprint Medicines.
Diversification Opportunities for Scpharmaceuticals and Blueprint Medicines
-0.26 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Scpharmaceuticals and Blueprint is -0.26. Overlapping area represents the amount of risk that can be diversified away by holding Scpharmaceuticals and Blueprint Medicines Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Blueprint Medicines Corp and Scpharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scpharmaceuticals are associated (or correlated) with Blueprint Medicines. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Blueprint Medicines Corp has no effect on the direction of Scpharmaceuticals i.e., Scpharmaceuticals and Blueprint Medicines go up and down completely randomly.
Pair Corralation between Scpharmaceuticals and Blueprint Medicines
Given the investment horizon of 90 days Scpharmaceuticals is expected to under-perform the Blueprint Medicines. In addition to that, Scpharmaceuticals is 1.24 times more volatile than Blueprint Medicines Corp. It trades about -0.03 of its total potential returns per unit of risk. Blueprint Medicines Corp is currently generating about 0.09 per unit of volatility. If you would invest 4,624 in Blueprint Medicines Corp on August 29, 2024 and sell it today you would earn a total of 4,886 from holding Blueprint Medicines Corp or generate 105.67% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Scpharmaceuticals vs. Blueprint Medicines Corp
Performance |
| Timeline |
| Scpharmaceuticals |
| Blueprint Medicines Corp |
Scpharmaceuticals and Blueprint Medicines Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Scpharmaceuticals and Blueprint Medicines
The main advantage of trading using opposite Scpharmaceuticals and Blueprint Medicines positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scpharmaceuticals position performs unexpectedly, Blueprint Medicines can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Blueprint Medicines will offset losses from the drop in Blueprint Medicines' long position.| Scpharmaceuticals vs. Milestone Pharmaceuticals | Scpharmaceuticals vs. Oncolytics Biotech | Scpharmaceuticals vs. Seres Therapeutics | Scpharmaceuticals vs. DiaMedica Therapeutics |
| Blueprint Medicines vs. Terns Pharmaceuticals | Blueprint Medicines vs. Amylyx Pharmaceuticals | Blueprint Medicines vs. Acumen Pharmaceuticals | Blueprint Medicines vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |